Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Farnesyltransferase inhibitors claimed by Banyu

Dec. 17, 1997

Aronex presents preliminary phase II results on Atragen

Dec. 16, 1997

Second-generation antisense antitumor compound from Hybridon enters clinic

Dec. 16, 1997

Total synthesis of aglaiastatin C, a natural antitumor alkaloid

Dec. 15, 1997

New FPP-based inhibitor of protein farnesyltransferase discovered at Banyu

Dec. 15, 1997

Eisai develops novel retinoids as highly potent and selective RXR agonists

Dec. 15, 1997

Genzyme Transgenics' idiotypic vaccines show promise in clinical trials

Dec. 12, 1997

MKT-077: a novel antitumor rhodacyanine dye in clinical testing

Dec. 11, 1997

Profile of novel topoisomerase II inhibitor, ER-37328, from Eisai

Dec. 11, 1997

Protein farnesyltransferase inhibitors focus of research at Merck & Co.

Dec. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...